TITLE

Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?

AUTHOR(S)
Marteau, P.
PUB. DATE
December 2006
SOURCE
Gut;Dec2006, Vol. 55 Issue 12, p1692
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on the ecological treatment for inflammatory bowel disease of probiotics, prebiotics, and synbiotics. An overview of the several studies conducted on probiotics, prebiotics, and synbiotics are offered. He views that these researches will offer a large field of potential applications for clinical and preclinical research, and will also lead to new treatments. He mentions that in patient with ulcerative colitis the ecological treatment may be beneficial.
ACCESSION #
23512258

 

Related Articles

  • LACTOBACILLUS PREVENTS RELAPSE IN ULCERATIVE COLITIS.  // Pulse;8/10/2006, Vol. 66 Issue 31, p25 

    The article focuses on the prevention of relapse in patients with ulcerative colitis through regular treatment with Lactobacillus rhamnosus GG. LGG has been used successfully to treat travellers' diarrhea and antibiotic-associated diarrhea. The evidence for the effectiveness of Lactobacillus...

  • Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Thomas, Saskia; Baumgart, Daniel // Inflammopharmacology;Feb2012, Vol. 20 Issue 1, p1 

    Crohn's disease and ulcerative colitis are two chronic inflammatory bowel diseases. Current biologic therapies are limited to blocking tumor necrosis factor alpha. However, some patients are primary non-responders, experience a loss of response, intolerance or side effects defining the urgent...

  • Mucosal Interleukin-8 Is Involved in Neutrophil Migration and Binding to Extracellular Matrix in Inflammatory Bowel Disease. Ina, Kenji; Kusugami, Kazuo; Yamaguchi, Takeo; Imada, Akira; Hosokawa, Takehiko; Ohsuga, Masahiro; Shinoda, Masataka; Ando, Takafumi; Ito, Katsuki; Yokoyama, Yasuhisa // American Journal of Gastroenterology;Aug1997, Vol. 92 Issue 8, p1342 

    Objectives: In this study, our purpose was to determine whether locally generated interleukin-8 (IL-8) is involved in neutrophil migration and binding to extra-cellular matrix, using the colonic mucosal specimens obtained from patients with inflammatory bowel disease (IBD). Methods: Levels of...

  • A Case of "Cap Polyposis"-Like Lesion Associated With Ulcerative Colitis: Is This a Case of Cap Polyposis? Tamura, Satoru; Onishi, Saburo; Ohkawauchi, Kohji; Miyamoto, Takako; Ueda, Hiroshi // American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3311 

    Describes a case of a cap polyposis-like lesion associated with ulcerative colitis in a 48-year-old female referred for evaluation of diarrhea and abdominal pain. Medical history of the patient; Medications received; Mechanism underlying cap polyposis-like lesion.

  • The Manitoba IBD Index: Evidence for a New and Simple Indicator of IBD Activity. Clara, Ian; Lix, Lisa M.; Walker, John R.; Graff, Lesley A.; Miller, Norine; Rogala, Linda; Rawsthorne, Patricia; Bernstein, Charles N. // American Journal of Gastroenterology;Jul2009, Vol. 104 Issue 7, p1754 

    OBJECTIVES:A single-item indicator of disease activity over an extended period of time, the Manitoba Inflammatory Bowel Disease Index (MIBDI), is introduced and compared against several standard measures for assessing activity in patients with Crohn's disease (CD) and ulcerative colitis...

  • The Month of Birth is Linked to the Risk of Crohn's Disease in the Israeli Population. Chowers, Yehuda; Odes, Shmuel; Bujanover, Yoram; Eliakim, Rami; Bar Meir, Simon; Avidan, Benjamin // American Journal of Gastroenterology;Oct2004, Vol. 99 Issue 10, p1974 

    OBJECTIVE: The main objective is to study whether the month of birth is associated with the development of Crohn's disease (CD) in the Israeli Jewish population.BACKGROUND: It was suggested that perinatal exposure to infectious agents may have a role in the pathogenesis of CD. Due to the...

  • Sulfasalazine and New Analogues. Friedman, Gerald // American Journal of Gastroenterology;Feb1986, Vol. 81 Issue 2, p141 

    Discusses research which focused on the use of sulfasalazine drugs for the treatment and prophylaxis of inflammatory bowel disease. Composition of the drug; Analysis of the efficacy of Pentasa in treating Crohn's disease; Contribution of Poly-ASA sulfasalazine oral formulation to the medical...

  • Can we prevent, reduce or reverse intestinal fibrosis in IBD? LATELLA, G.; SFERRA, R.; SPECA, S.; VETUSCHI, A.; GAUDIO, E. // European Review for Medical & Pharmacological Sciences;May2013, Vol. 17 Issue 10, p1283 

    Intestinal fibrosis is a common complication of in inflammatory bowel disease (IBD) and can occur in both ulcerative colitis (UC) and Crohn's disease (CD), but is much more prevalent in CD. Fibrosis is a consequence of local chronic inflammation and is characterized by abnormal deposition of...

  • CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease. Alexander Rodgers; Adrian Cummins // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2063 

    Abstract  The aim of this study was to prospectively evaluate the correlation between clinical scoring systems and C-reactive protein (CRP) in inflammatory bowel disease. The modified Harvey-Bradshaw index was used in 40 patients (58 assessments) with Crohn’s...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics